article thumbnail

UK Article: Why Don’t We Just… reschedule psilocybin?

Cannabis Law Report

Firstly, psychedelics are administered infrequently in controlled settings with up to only three treatments shown to produce long lasting benefits in clinical trials so far. It is extremely expensive (over £20,000 for one clinical trial), bureaucratic and incurs large time delays (up to one year). of charge on the NHS.

article thumbnail

UK: Tory MP Crispin Blunt At Loggerheads With The Home Office Over Psilocybin Research

Cannabis Law Report

A Home Office spokesperson said: “There is an established process for the development of medicines, which enables medicines including psilocybin to be developed, evaluated in clinical trials and licensed based on an assessment of their quality, safety and efficacy. Source: [link].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Cannabis Law Report

(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain.

article thumbnail

UK Baker & McKenzie Article – United Kingdom: London’s First Medical Cannabis Clinic Opens to Waiting List

Cannabis Law Report

The opening of private cannabis clinics in the UK is in response to the British Home Office making medicinal cannabis legal from 1 November 2018, reclassifying it from Schedule 1 to Schedule 2 under the 2001 Misuse of Drugs Regulations. The new legislation permits specialist doctors to legally prescribe cannabis-based medicines.

article thumbnail

Medicinal Cannabis – How far have we really come?

Cannabis Law Report

Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinical trials. Acting on a broad range of cases, all with a medical or injury element, usually on the instructions of insurers. Legalisation.

article thumbnail

Why we haven’t cured cancer

Otherside Farms

cancer cells (full – 2001). Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1 (full – 2001). full – 2001). Anti-Tumor Effects (news – 2001?). Anti-Tumor Effects (news – 2001?). Clinical Studies and Case Reports. 10.1096/fj.02-0795fje

article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., After the full-text analyses, 14 were selected for the present review. Most studies were published in the last five years, while the rest were published between 1994 and 2008.

Therapy 98